Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people notice Mounjaro working within the first one to two weeks — not dramatic weight loss, but a clear shift in hunger and fullness signals. By week four, many report eating noticeably less without consciously trying. Significant, measurable weight loss tends to build from month two onwards, accelerating as the dose increases over the following months. Mounjaro (tirzepatide) is a prescription-only medicine; a GPhC-registered prescriber assesses whether it is clinically suitable for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The 2.5mg starting dose exists for one reason: to give your digestive system time to adapt to tirzepatide's dual GIP and GLP-1 receptor action before the real therapeutic work begins. Expecting rapid weight loss at this stage is the most common misunderstanding our prescribers hear, and it is worth letting go of. The 2.5mg dose slows gastric emptying and begins to recalibrate appetite signals, but it is designed primarily for tolerability.
What you will likely notice first is subtler: food feeling more satisfying at smaller portions, a quieter urge to snack between meals, or finishing a plate and genuinely not wanting more. Some people also experience nausea, mild digestive discomfort or fatigue, particularly in the days after the first or second injection. These side effects are usually short-lived. The NHS's patient information on tirzepatide gives a full list of what to expect and when to seek help.
On the scales, change in week one to four is typically modest, often a kilogram or two, sometimes less. That is not a sign the medicine is failing. It is the system bedding in.
After four weeks, most people move to the 5mg dose, and this is where many start to see a clearer shift in weight. The appetite suppression that felt partial at 2.5mg tends to become more consistent. Meals feel satisfying faster. The pull toward high-calorie foods often diminishes noticeably.
For people wondering how quickly Mounjaro will work in practical terms, this phase is usually the first honest answer: by weeks eight to twelve, a loss of around 5–8% of starting body weight is common in clinical trial data, though individual responses vary. Your prescriber reviews your progress before any dose increase, at nume, that review happens before every repeat order, not just at the start.
Side effects tend to peak around dose-increase moments and then settle again. Staying well-hydrated and eating protein-rich meals helps considerably. If side effects feel unmanageable, that is a conversation to have with your prescriber, not a reason to stop silently.
Continuing titration through 7.5mg and 10mg through months three to six is typically when people who started Mounjaro describe their most significant visible changes. Appetite suppression at these doses is substantially stronger than at the starting level, and many find their dietary habits have shifted in ways that feel almost automatic rather than effortful.
The SURMOUNT-1 trial published in the New England Journal of Medicine followed 2,539 adults with obesity over 72 weeks, and by week 24 (roughly six months), participants on the highest doses had already achieved around 15% average weight loss. The full 20–21% average reduction emerged over the complete 72-week period. If you want a clearer picture of how quickly Mounjaro works for weight loss at each stage of treatment, our dedicated guide walks through the evidence in detail.
It is also worth knowing that weight loss is not the only marker of how quickly Mounjaro starts to work, since blood pressure, cholesterol levels, blood glucose and sleep quality often improve before the scales reflect the full picture. These internal shifts matter.
For those who progress to 12.5mg or 15mg, weight loss generally continues beyond the six-month mark, often more slowly but still meaningfully. The body's response to tirzepatide does not switch off; it continues as long as the medicine is taken and lifestyle changes are maintained alongside it.
A note on keeping weight off after Mounjaro: the evidence is clear that weight tends to return when the medicine stops without sustainable habits in place. That is why every plan includes support for what comes next, not just the injection schedule. Thinking about how quickly tirzepatide works across the full programme helps set realistic expectations from the beginning.
If you are weighing up the cost of treatment over this timeline, our Mounjaro price comparison guide explains what a legitimate private prescription typically includes and why the headline price is rarely the full picture. When you are ready to see whether you would be clinically suitable, check your eligibility with our prescribers, no waiting list, no referral needed, just a clinical assessment the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.